Answer
Lebrikizumab (Ebglyss) is injected subcutaneously into the thigh or abdomen, excluding 5 cm around the navel, or the upper arm if someone else administers it; rotate sites and avoid tender, damaged, bruised or scarred skin.
Sources for this answer
- Ebglyss 250 mg solution for injection in pre-filled syringeAlmirall Limited · emc · SmPC §4.2 Posology and method of administration · Version 5Document updated
Sources checked